No Data
No Data
Nikka Chemical: 2024 performance forecast
Shandong Rike Chemical (300214.SZ) plans to invest 30 million to 50 million yuan to buy back shares.
Shandong Rike Chemical (300214.SZ) announced that the company plans to spend 30 million to 50 million yuan to repurchase shares...
Shandong Rike Chemical (300214.SZ): There is currently no relevant technology reserves for neural training networks.
Gelonghui, January 2nd丨Shandong Rike Chemical (300214.SZ) stated on the investor interaction platform that the company currently has no technical reserves related to neural training networks.
Nikke Chemical: Report for the third quarter of 2024
October 23rd A-share investment lightning rod: Humanwell Healthcare: the controlling shareholder received a notice of investigation from the CSRC; Jiangsu Jiangnan High Polymer Fiber: Shareholder Ye Jinyou plans to reduce shareholding by no more than 1%.
Sichuan Shudao Equipment & Technology shareholder Jianyang Gangtong plans to reduce their shareholding by no more than 2.0499%; Jiangsu Jiangnan high polymer fiber shareholder Ye Jinyou plans to reduce their shareholding by no more than 1%; Beijing Inhand Networks Technology shareholder De Fengjie plans to reduce their shareholding by no more than 2.00%; shareholder of Changying Tong Xin Jun plans to reduce their shareholding by no more than 3%; Shandong Rike Chemical had a net loss of 52.3315 million yuan in the first three quarters; Humanwell Healthcare and its controlling shareholder received a notice from the China Securities Regulatory Commission about the case being filed; Shanghai Lily&Beauty Cosmetics' actual controller Huang Tao had 1.75% of their shares frozen.
Shandong Rike Chemical (300214.SZ): a net loss of 52.3315 million yuan in the first three quarters.
Rike Chemical (300214.SZ) announced on October 22nd that the company's revenue for the first three quarters was 2.415 billion yuan, a year-on-year increase of 26.77%; net income attributable to the shareholders of the listed company was -52.3315 million yuan.